NCT00819728View on ClinicalTrials.gov

Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2000

Study Completion Date

January 31, 2003

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Docetaxel

35mg/m2 IV each week for 4 weeks

DRUG

Irinotecan

50mg/m2 IV each week for 4 weeks

Trial Locations (1)

08807

Sanofi-Aventis US, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY